ALCALDE XXIII

April 16-17, 2009

Austin, TX

PLATFORM PRESENTATIONS

Alcalde XXIII, the Twenty-third Annual Southwest Leadership Conference, intends to provide encouragement and learning experiences which will promote creativity, Scholarship and leadership and will promote the presentation of evidence based research at national meetings. To the extent possible, the process adopted for presentation at Alcalde is patterned after that of ASHP, so as to provide a practical experience in getting ready for a national presentation. All residents and fellows are strongly encouraged to submit abstracts of papers to be presented at SWLC for pharmacy residents, fellows, and preceptors.

The presentation format includes 15 minutes of lecture and five minutes of questions-and-answers. The presentation must be in a Power Point format; an LCD Projector and screen will be provided. Abstracts should be submitted no later than February 28, 2009 via e-mail.  Residents and fellows must submit their presentation in PowerPoint format no later than Friday, March 21, 2009.  Changes to presentations will not be allowed after this time.  Please submit the PowerPoint presentation with a title using your name; E.g. JaneResident.ppt to Linda Albrecht at lalbrech@yahoo.com.

Click here to view important deadlines for the TSHP Poster Competition and Alcalde.

Papers are sought in the following categories for platform presentation:

CLINICAL RESEARCH

This category includes reports of well-conducted original research on drug effects in humans. Examples of topics that might be covered include the following:

· comparative efficacy and safety evaluations of two or more drug therapies;

· exploratory studies on the clinical pharmacology and pharmacokinetics of  investigational  drugs;

· analyses of the incidence and severity of adverse drug reactions;

· bioavailability studies in human subjects; and

· comparative evaluations of the clinical usefulness of various laboratory methods.

COMMAND PERFORMANCE REPORTS

This category includes clinical research reports that have been presented elsewhere. Submissions must be reports of original research in clinical or laboratory research.

EVALUATIVE STUDIES

These submissions must report completed original research. Included in this category are evaluative studies of new roles or services in institutional pharmacy practice.

DESCRIPTIVE REPORTS

These are contributions reporting new, improved, or innovative roles or services in pharmacy practice that have not been evaluated formally, but are of such importance that they should be brought to the attention of other practitioners. Also, reports of clinical cases that do not meet the criteria for evaluative studies fall into this category. Examples of the latter include reports of unusual drug reactions involving only one or a few patients or unique uses of drugs in a limited number of patients when the drugs involved are important therapeutic agents.

RESEARCH-IN-PROGRESS

These reports present uncompleted evaluative studies (or clinical/laboratory research) that are currently in progress and will most likely still be in progress at the time of the meeting. Research-in-progress reports allow investigators to bring their projects to the attention of colleagues earlier than would otherwise be possible. In addition, a forum is provided for investigators to benefit from peer review at a stage when appropriate modifications can still be made in study methods, data collection and analysis or interpretation of results.

CASE STUDIES IN HOSPITAL PHARMACY MANAGEMENT

These management case studies are intended to take the audience through an analysis of the sequential steps or processes involved in resolving a particular problem, implementing a change, developing and implementing a new system or program, planning and organizing an administrative function, or some other example of applied institutional pharmacy management. The primary objective is not simply to offer a forum for the presenter to tell the audience what was done, but rather to join the audience in a critical analysis of the case.

LABORATORY RESEARCH

One component of each of the specialty residency standards for accreditation by ASHP is an investigational or research project. There are also a number of Clinical Sciences Fellowship programs in the Southwest, and these are especially oriented toward research. In some cases laboratory research is conducted, and the SWLC would encourage persons engaged in this type of scholarly work to present reports on completed projects or in the category, "Research-in-Progress." (ASHP does not include "Laboratory Research" as one of its categories.) 

SELECTED PRESENTATIONS (Examples) – Alcalde XIX

LIPID MANAGEMENT

A Retrospective Study of the Lipid-Lowering Efficacy and

Safety of Within-NNRTI Switching in HIV-Infected Patients

Comparison of Atorvastatin and Ezetimibe/Simvastatin for the Control of LDL-Cholesterol

Assessing the Impact of Statin Therapy on Ventilator-Associated Biotrauma

INFECTIOUS DISEASE

Implications of an Antibiotic Restriction Program on the

Treatment of Catheter-Related Urinay Tract Infections

Quality Assurance of a Pharmacokinetic Consult Service for

Aminoglycosides and Vancomycin Within a Large Health Care System

Trends in Treatment of Clostridium dificile Associated Disease in a Community Hospital Setting

Cephalosporin Cross-Reactivity in Patients with a History of Penicillin Allergy

CARDIOVASCULAR MEDICINE

Impact of a Pharmacist-Managed Anticoagulation Clinic on

Patient Outcomes in as Community-Owned Healthcare System

Negative and Positive Predictors of Compliance in Patients with Heart Failure

A Multi-Center Retrospective Study on the Clinical Efficacy and Safety on

Lipid Lowering Effects after a Switch to Atazanavir/Ritonavir-based HAART

HEMATOLOGY/ONCOLOGY

Efficacy and Toxicity of a Second Autologous Peripheral Blood Stem

Cell Transplant for Patients with Relapsed or Recurrent Multiple Myeloma

Evaluation of Leucovorin Rescue and Hydration with

High Dose Methotrexate in Pediatric Osteosarcoma Patients

Evaluation of Polymorphic Differences in RAF Kinase Isoforms Between

HER 2-Positive and HER 2-Negative Breast Cancer Patients

DIABETES

Evaluation of Cost-Effective and Evidence-Based Management of

Type 2 Diabetes Mellitus in an Academic VA

Evaluation of Clinical and Economic Outcomes of a Member Benefit Medication Therapy Management Program with Co-Payment Waiver for High Risk

Managed Care Patients with Diabetes

Assessment of an Intensive Insulin Drip Protocol at a Tertiary Care Hospital

PEDIATRICS

Maximizing Total Parenteral Nutrition (TPN) in Acute

Care Patients in a Pediatric Teaching Institution

Antibiotic Selection in Treating Pediatric Community Acquired

Skin/Soft Tissue Infections Caused by Staph aureus

CLINICAL PRACTICE

Cost Avoidance Associated with Clinical Pharmacists' Interventions in the Emergency Department

Incidence and Prevention of Intravenous Contrast-Induced Nephropathy in an Acute Care Setting

PHARMACEUTICAL CARE

Development and Implementation of a Pharmacist-Run Medication

Education Program Focusing on Adherence to Antipsychotic Agents

Cost Savings Associated with Formulary management Strategies for

Antidepressant Drugs and the Resulting Clinical Implications

AMBULATORY CARE

Transdermal Fentanyl use in the Emergency Department

Evaluation of the Quality of Care of Patients with Depression in a

Family Medicine Primary Care Practice

For a complete set of abstracts from the 2008 Conference, click here.

Alcalde, the Spanish title for the mayor of the town or village, is derived from the Arabic word al-qadi, or "judge".  Fortunately the term was applied to local government officials whose functions were varied but always included a judicial element.  Types of alcalde were differentiated according to the specialized nature of their judicial functions:  the alcalde de corte was a judge in the palace court with jurisdiction in and about the residence of the king; the alcalde mayor assisted the judges appointed by the king in the towns.  Since the 19th Century, the alcalde has had the dual role of the local council and representative of the central government.  The pharmacy resident, fellow or preceptor must also serve a dual role as a leader among his or her peers and as a representative of the profession.